<?xml version="1.0" encoding="ISO-8859-1"?>

<?xml-stylesheet type="text/css" href="https://www.webwire.com/includes/rssstyle.css"?>

<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
  
  <!-- Issuers of news/press releases and NOT WebWire are solely responsible for the accuracy of the content. -->



    <title>WebWire | News by Industry : Health Care / Hospitals</title>
    <link>https://www.webwire.com/</link>
    <description>Health Care / Hospitals News by WebWire</description>
    <language>en-US</language>
    <copyright>Copyright &#169; 2026 WebWire. All Rights Reserved.</copyright>
    <ttl>15</ttl>
    <lastBuildDate>Thu, 18 Jun 2026 17:31:35 EDT</lastBuildDate>
	<image>
      <title>WebWire | News by Industry : Health Care / Hospitals</title>
      <width>140</width>
      <height>32</height>
      <link>https://www.webwire.com/</link>
      <url>https://www.webwire.com/imgs/webwire_logo_140x32.gif</url>
    </image>
	

  <item>
     <title>Vali Health Raises $6M to Build Responsible AI Infrastructure for Home Care Agencies</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356384</link>
     <pubDate>Wed, 17 Jun 2026 09:35:05 EDT</pubDate>
     <description><![CDATA[<p>  Vali Health, a startup building responsible AI infrastructure for the home care industry, today emerged from stealth with $6 million in funding from Bonfire Ventures, Supernode, Comma Capital, along with Jacquelyn Kung, an industry veteran who built two of the largest software platforms for home care. Vali&#39;s AI agents enable home care agencies to automate workforce management and coordination, while maintaining trust and safety front and center. -   -   Home Care&#39;s Opportunity: A Mission-Crit...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356384">https://www.webwire.com/ViewPressRel.asp?aId=356384</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/81468/356384/356384-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356384</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>&#8220;Beyond Feet on Fire,&#8221; Best-Selling Book Offered for Free (Ending Soon) (Until 6/19/26)</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356242</link>
     <pubDate>Wed, 17 Jun 2026 06:00:00 EDT</pubDate>
     <description><![CDATA[<p> Best Seller Publishing announces the release of Dr. Paul Fisher&#39;s new book,   &#8220;Beyond Feet on Fire: How To Reverse Neuropathy Without Drugs and Surgery.&#8221;   It will be available in the Amazon store for free for two more days. -   -    &#8220;Beyond Feet on Fire&#8221;   is about understanding neuropathy as more than just a nerve disorder&#8212;it is a complex breakdown involving metabolism, circulation, and neurological communication. Drawing on years of clinical experience and extensive research, Dr. Paul Fishe...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356242">https://www.webwire.com/ViewPressRel.asp?aId=356242</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/40662/356242/356242-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356242</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>A tiny ingestible sensor can measure temperature from inside the body</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356315</link>
     <pubDate>Tue, 16 Jun 2026 08:00:21 EDT</pubDate>
     <description><![CDATA[<p> In a hospital or at home, temperatures are usually taken using an oral or forehead thermometer, but these do not always accurately reflect the core body temperature. Measuring core temperature from within the body could make it easier to determine whether someone is sick, and whether they&#39;re at risk of spiking a dangerous fever. -   -  To make it more feasible to obtain core body temperature measurements, MIT engineers have developed an ingestible sensor that can send continuous temperature up...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356315">https://www.webwire.com/ViewPressRel.asp?aId=356315</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/356315/356315-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356315</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>ATA Action Bringing Top Federal Policy Priorities to Capitol Hill to Support Permanent Access to Virtual Care and Digital Health Tools</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356309</link>
     <pubDate>Tue, 16 Jun 2026 07:29:55 EDT</pubDate>
     <description><![CDATA[<p>  ATA Action, the affiliated policy and legislative advocacy arm of the  American Telemedicine Association, met with 35 Congressional offices, House and Senate leadership offices, and key committee leaders during its 4 th  annual Hill Day on June 10, to advance federal policies that support permanent access to telehealth and digital health tools and encourage innovation in technology-enabled care. -   -  &#8220;ATA Action members are coming to Capitol Hill with a clear message: the time to act is now...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356309">https://www.webwire.com/ViewPressRel.asp?aId=356309</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/356309/356309-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356309</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Alicia Baca Rush&#39;s &#8220;The Good Kind of Cancer&#8221; To Be Displayed at a Book Festival at Printers Row, Chicago</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356284</link>
     <pubDate>Mon, 15 Jun 2026 20:58:30 EDT</pubDate>
     <description><![CDATA[<p> Alicia Baca Rush&#39;s book,  &#8220;The Good Kind of Cancer: Turning Pain Into Purpose &#8212; One Day At A Time &#8212; A Health Mem�ria,&#8221;  will be showcased by the self-publishing and book marketing company ReadersMagnet at an upcoming book festival at Printers Row in Chicago. The event will take place on September 12-13, 2026, along the historic South Dearborn Street corridor from Ida B. Wells to Polk. -   -  In her moving memoir, Alicia recounts her journey through the harsh realities of Stage 2 thyroid cancer...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356284">https://www.webwire.com/ViewPressRel.asp?aId=356284</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/55089/356284/356284-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356284</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Heartseed Announces First Patient Dosed in a Phase I/II EMERALD Study with HS-005 &#8211; a Cell Therapy Administered via Catheter, Designed to Restore Heart Function in People with Severe Heart Failure</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356264</link>
     <pubDate>Mon, 15 Jun 2026 12:16:05 EDT</pubDate>
     <description><![CDATA[<p> Nikon CeLL innovation Co., Ltd. (NCLi), a subsidiary of Nikon Corporation (Nikon), manufactures iPSC-derived purified cardiomyocyte spheroids of HS-005, under contract to Heartseed Inc.(Heartseed). -   -  Heartseed today announced that the successful dosing of the first patient in its domestic phase I/II clinical trial (EMERALD Study) of HS-005 which utilizes a catheter system for endocardial delivery to administer cardiomyocyte spheroids for patients with severe heart failure with reduced eje...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356264">https://www.webwire.com/ViewPressRel.asp?aId=356264</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/8/356264/356264-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356264</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>New tool for measuring synbiotic synergy potential could shape the next wave of food and drink innovation supporting gut health</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356259</link>
     <pubDate>Mon, 15 Jun 2026 11:00:42 EDT</pubDate>
     <description><![CDATA[<p> Tate &amp; Lyle PLC (Tate &amp; Lyle), a global leader in ingredient solutions for healthier food and beverages, welcomes the publication of a new peer-reviewed study from world-leading APC Microbiome Ireland at University College Cork, supported in part by research grants from Tate &amp; Lyle and Research Ireland. The study introduces a new tool, designed to improve the potential gut health outcomes and the quality and speed of development of synbiotic ingredient combinations for the food, beverage a...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356259">https://www.webwire.com/ViewPressRel.asp?aId=356259</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/7/356259/356259-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356259</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>CONV2X Announces Smart Technology Transformation in Healthcare &amp; Life Sciences Summit in New York City</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356147</link>
     <pubDate>Mon, 15 Jun 2026 10:56:45 EDT</pubDate>
     <description><![CDATA[<p>  CONV2X Smart Technology Transformation in Healthcare &amp; Life Sciences, announced its annual two-day executive summit taking place October 29&#8211;30, 2026 at the Historic GE Building, ILR Conference Center, 570 Lexington Avenue, New York, NY. -   -  Themed  Beyond the Pilot, the conference addresses a defining challenge of 2026: healthcare implementation &#8212; deploying AI, telehealth, and smart technology at enterprise scale with measurable outcomes, sustainable economics, and sound governance. -   -   Op...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356147">https://www.webwire.com/ViewPressRel.asp?aId=356147</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/54628/356147/356147-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356147</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Elsevier launches Ebola Information&amp;#8239;Center&amp;#8239;with free clinical and research resources to support response to outbreak</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356256</link>
     <pubDate>Mon, 15 Jun 2026 10:54:14 EDT</pubDate>
     <description><![CDATA[<p> Following the World Health Organization&#39;s declaration of an Ebola outbreak caused by Bundibugyo virus in the Democratic Republic of Congo and Uganda as a Public Health Emergency of International Concern (PHEIC), Elsevier, a global leader in scientific information and analytics, has launched its  Ebola Information Center   to provide healthcare professionals, researchers, policy makers and the public with free access to critical clinical and research information to support the global respon...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356256">https://www.webwire.com/ViewPressRel.asp?aId=356256</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/356256/356256-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356256</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Ultomiris granted Priority Review in the US as treatment for adults with immunoglobulin A nephropathy</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356253</link>
     <pubDate>Mon, 15 Jun 2026 10:48:37 EDT</pubDate>
     <description><![CDATA[<p>   Based on I CAN Phase III trial results from prespecified interim analysis in which Ultomiris demonstrated 43.4% reduction in proteinuria vs placebo at 34 weeks   -   -    If approved, Ultomiris would be the first C5 complement inhibitor available for this rare kidney disease   -   -  Alexion, AstraZeneca Rare Disease&#39;s supplemental Biologics License Application (sBLA) for  Ultomiris  (ravulizumab) has been accepted and granted Priority Review by the US Food and Drug Administration (FDA) for the...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356253">https://www.webwire.com/ViewPressRel.asp?aId=356253</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/356253/356253-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356253</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Caring for non-communicable diseases during pregnancy, expert convening</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356247</link>
     <pubDate>Mon, 15 Jun 2026 10:36:28 EDT</pubDate>
     <description><![CDATA[<p> The World Health Organization (WHO) is developing new recommendations to improve care for pregnant and postpartum women living with noncommunicable diseases (NCDs). -   -  Around the world, more pregnancies are being affected by NCDs such as diabetes, high blood pressure, heart conditions, obesity and other long-term health problems. These conditions may already exist before pregnancy or develop during it. NCDs are  now a major cause of poor health among women of reproductive age  and are incr...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356247">https://www.webwire.com/ViewPressRel.asp?aId=356247</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/356247/356247-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356247</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>&#8220;Beyond Feet on Fire&#8221; is Free to Download for Only Five Days (Until 6/19/26)</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356184</link>
     <pubDate>Mon, 15 Jun 2026 06:00:00 EDT</pubDate>
     <description><![CDATA[<p> Best Seller Publishing announces the release of Dr. Paul Fisher&#39;s new book,  &#8220;Beyond Feet on Fire: How To Reverse Neuropathy Without Drugs and Surgery.&#8221;   It will be available in the Amazon store for free for only five days. -   -    &#8220;Beyond Feet on Fire&#8221;   is about understanding neuropathy as more than just a nerve disorder&#8212;it is a complex breakdown involving metabolism, circulation, and neurological communication. Drawing on years of clinical experience and extensive research, Dr. Paul Fishe...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356184">https://www.webwire.com/ViewPressRel.asp?aId=356184</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/40662/356184/356184-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356184</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Bombardier Defense Expands Collaboration with Aero-Dienst/ADAC with a Second Challenger 650 Aircraft for Medevac</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356179</link>
     <pubDate>Fri, 12 Jun 2026 10:48:35 EDT</pubDate>
     <description><![CDATA[<p> -    -  &#8226; Bombardier Defense signs deal with German-based operator Aero-Dienst GmbH, a wholly owned subsidiary of ADAC SE, for a second Bombardier  Challenger 650  aircraft that will be added to its medevac fleet -  &#8226; The  Challenger 650  aircraft supports critical missions worldwide with proven reliability, long-range performance and cabin flexibility  -  &#8226; Additional aircraft reinforces Bombardier Defense as a trusted partner in Germany and Europe -    -   -   Bombardier Defense is pleased to announce...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356179">https://www.webwire.com/ViewPressRel.asp?aId=356179</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/356179/356179-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356179</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Johnson &amp; Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356176</link>
     <pubDate>Fri, 12 Jun 2026 10:38:47 EDT</pubDate>
     <description><![CDATA[<p> &#8226; Expanded U.S. availability paired with new patient lifestyle quiz encourages informed decision-making ahead of cataract surgery.  -   &#8226; Cataracts are one of the leading causes of vision impairment.1  Nearly 20% of Americans aged 40+ live with cataracts that make everyday tasks more challenging, yet only 5% have had cataract surgery.2   -   &#8226; Over half a million eyes worldwide have already experienced clearer, extended range of vision with TECNIS PureSee IOL after cataract surgery.3,4   -   &#8226; 9...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356176">https://www.webwire.com/ViewPressRel.asp?aId=356176</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/356176/356176-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356176</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356074</link>
     <pubDate>Wed, 10 Jun 2026 18:17:01 EDT</pubDate>
     <description><![CDATA[<p> Sanofi today announced that the riliprubart MOBILIZE phase 3 study (clinical study identifier: NCT06290128) in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) refractory to standard-of-care treatment will be stopped. This decision follows an interim analysis by an independent data monitoring committee, which determined that the MOBILIZE study is unlikely to provide sufficient efficacy. No safety signals related to riliprubart were identified as part of this interim a...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356074">https://www.webwire.com/ViewPressRel.asp?aId=356074</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/8/356074/356074-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356074</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Huawei Launches the &#34;AHEAD&#34; Program to Build a New Ecosystem for Mutual Benefits in Education and Healthcare</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356070</link>
     <pubDate>Wed, 10 Jun 2026 18:10:47 EDT</pubDate>
     <description><![CDATA[<p> The 2026 Global Education &amp; Healthcare Partners Convention, convened under the theme &#8220;Together, Enabling Intelligent-led Education &amp; Healthcare,&#8221; successfully concluded in China. The event drew over 500 industry customers and partners across more than 40 countries and regions. At the event, Huawei unveiled the Alliance on Healthcare &amp; Education AI Digitalization 2.0&#8212;&#8212;&#8220;AHEAD&#8221; Program, dedicated to forging tighter industry synergy and cultivating a sustainable, high-caliber ecosystem. -   -   AI...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356070">https://www.webwire.com/ViewPressRel.asp?aId=356070</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/8/356070/356070-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356070</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Message by the Director of the Department of Immunization, Vaccines and Biologicals at WHO - May 2026</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356034</link>
     <pubDate>Wed, 10 Jun 2026 09:20:39 EDT</pubDate>
     <description><![CDATA[<p> At the mid-way point of Immunization Agenda 2030 (IA2030), countries gathering at the  Seventy-ninth World Health Assembly  (WHA79) marked an important moment in reaffirming their commitment to reaching everyone, everywhere with life-saving vaccines.  -   -  Member States and global health partners strongly reasserted their support for the strategy, goals, and programmatic implementation of IA2030, recognizing immunization as one of the most powerful, cost-effective and equitable health interv...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356034">https://www.webwire.com/ViewPressRel.asp?aId=356034</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/356034/356034-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356034</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>AMA adopts new policies to improve affordable access to obesity treatments</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355989</link>
     <pubDate>Tue, 9 Jun 2026 09:02:36 EDT</pubDate>
     <description><![CDATA[<p> Physicians and medical students convened for the Annual Meeting of the American Medical Association&#39;s (AMA) House of Delegates today and adopted new policies aimed at improving patient access to evidence-based obesity treatments while advancing broader efforts to address prescription drug affordability and insurance coverage barriers. -   -  The new policies build upon longstanding AMA policy supporting affordable access to prescription medications, prescription drug price transparency, pharma...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355989">https://www.webwire.com/ViewPressRel.asp?aId=355989</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355989/355989-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355989</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Wiley Launches Advanced Brain to Push Disciplinary Boundaries Across Neuroscience &amp; Related Fields</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355967</link>
     <pubDate>Tue, 9 Jun 2026 08:08:00 EDT</pubDate>
     <description><![CDATA[<p> Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence, today announced the launch of  Advanced Brain, an open access, interdisciplinary journal dedicated to publishing cutting-edge research across neuroscience, neurology, psychiatry and psychology. The new journal, part of Wiley&#39;s Advanced Portfolio of high-impact collaborative journals, is now open for submissions. -   -   Advanced Brain  is designed to further both fundamental and applied understanding of the...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355967">https://www.webwire.com/ViewPressRel.asp?aId=355967</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355967/355967-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355967</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Mental health: although screens can play a negative role, more than 6 out of 10 people turn to artificial intelligence for psychological support</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355932</link>
     <pubDate>Mon, 8 Jun 2026 17:23:06 EDT</pubDate>
     <description><![CDATA[<p> -    -  &#8226; AXA and Ipsos have surveyed people in 18 countries about their mental health, which continues to decline. 46% of those surveyed say they are struggling or languishing. -   -   &#8226; Do new technologies play a role in this deterioration? Two out of three respondents consider that screens have a negative impact on their mental health, even though they spend over 5 hours per day on average on screens (excluding working hours and excluding weekends). -   -   &#8226; Yet technology can also play a positive...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355932">https://www.webwire.com/ViewPressRel.asp?aId=355932</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/7/355932/355932-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355932</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Sanofi&#39;s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355917</link>
     <pubDate>Mon, 8 Jun 2026 10:37:39 EDT</pubDate>
     <description><![CDATA[<p>  Sanofi&#39;s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector   -   -    -  &#8226; Sarclisa administered via the CirCLIQ &#174;  OBI offers a treatment experience designed around the needs of patients and HCPs and enables flexible administration in either home or outpatient settings -  &#8226; Sarclisa is the first anticancer treatment to be administered through an OBI and the first MM treatment available by both SC OBI and manual injection in the EU -  &#8226;...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355917">https://www.webwire.com/ViewPressRel.asp?aId=355917</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355917/355917-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355917</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Thrifty Food Plan Costs Vary Widely Across US Regions and Cities</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355898</link>
     <pubDate>Mon, 8 Jun 2026 09:58:55 EDT</pubDate>
     <description><![CDATA[<p> A  recent study  in the   Journal of Nutrition Education and Behavior   (JNEB), published by Elsevier, examined how the cost of the USDA&#39;s Thrifty Food Plan (TFP), which serves as the basis for determining maximum SNAP benefits, varied across geographic regions, metropolitan areas, and seasons from 2012 to 2018. Researchers found that where a household is located plays a much larger role in the cost of a healthy diet than year-to-year inflation. -   -  Researchers used USDA Food-at-Home Monthl...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355898">https://www.webwire.com/ViewPressRel.asp?aId=355898</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355898/355898-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355898</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Can taking aspirin uncover asymptomatic bladder cancer?</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355816</link>
     <pubDate>Fri, 5 Jun 2026 09:21:01 EDT</pubDate>
     <description><![CDATA[<p> The presence of blood cells in urine is a sign of bladder cancer. Because aspirin blocks platelets from forming harmful blood clots, the medication can cause mild bleeding or worsen existing bleeding in the urinary tract. Results from a study in the   Journal of Internal Medicine   suggest that this may prompt a clinician to run tests that uncover an asymptomatic bladder tumor. -   -  For the study, investigators analyzed information on 50,771 Danish adults who started taking aspirin in 2005&#8211;2...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355816">https://www.webwire.com/ViewPressRel.asp?aId=355816</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355816/355816-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355816</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Increased transport costs mean less money for the lifesaving supplies children need</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355769</link>
     <pubDate>Thu, 4 Jun 2026 10:20:00 EDT</pubDate>
     <description><![CDATA[<p> &#8220;Nearly 100 days into the latest Middle East escalation, the fallout extends far beyond the region. The disruption to global humanitarian supply chains is impacting children across the globe, with continued congestion in global supply routes, and higher transport costs at all levels.  -   -  &#8220;Increased transport costs mean less money for the lifesaving supplies children need. These pressures are rendering the margins for error for organizations, like UNICEF, precarious.  -   -  &#8220;What begins as a d...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355769">https://www.webwire.com/ViewPressRel.asp?aId=355769</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355769/355769-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355769</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Rick Hansen Foundation, RBC and RBC Foundation Announce 40 Recipients of the RBC Barrier Buster Grants Program</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355702</link>
     <pubDate>Wed, 3 Jun 2026 10:18:29 EDT</pubDate>
     <description><![CDATA[<p> -    -  &#8226; Forty communities across Canada -- including municipalities, schools and community groups -- will each receive grants of up to $40,000 to fund physical accessibility improvements through RBC Barrier Buster Grants Program. -   -   &#8226; Over half (64 per cent) of Canadians have a disability or live with or take care of someone who does -- making this program relevant to the majority of Canadian households. -   -     -   -   Traditional territory of the x&amp;#695;m&amp;#601;&amp;#952;kw&amp;#601;y &amp;#787;&amp;#601;m (Mus...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355702">https://www.webwire.com/ViewPressRel.asp?aId=355702</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355702/355702-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355702</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Kaiser Permanente names Emily Holliman president of Mid-Atlantic States region</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355699</link>
     <pubDate>Wed, 3 Jun 2026 10:07:22 EDT</pubDate>
     <description><![CDATA[<p>    Kaiser Permanente has appointed Emily Holliman as president of Kaiser Permanente in the Mid-Atlantic States, effective immediately. Holliman has served as the region&#39;s interim president since June 2025, leading efforts to provide high-quality, integrated health care and coverage to the organization&#39;s 750,551 members across 35 medical centers in Maryland, Virginia, and Washington, D.C. -   -  A proven health care leader with more than 20 years of experience, Holiman brings deep experience in...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355699">https://www.webwire.com/ViewPressRel.asp?aId=355699</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355699/355699-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355699</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Johnson &amp; Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355698</link>
     <pubDate>Wed, 3 Jun 2026 10:03:16 EDT</pubDate>
     <description><![CDATA[<p>�  Nipocalimab &#8211; the first and only neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus &#8211; is designed to target and reduce pathogenic immunoglobulin G (IgG) autoantibodies associated with this disease while preserving immune function  -   -  �  Results demonstrated significant reduction of systemic lupus erythematosus disease activity which continued beyond the 24-week primary endpoint, and were sustained through Week 52 in the nipocalimab 15 mg/kg group a   -   -  � ...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355698">https://www.webwire.com/ViewPressRel.asp?aId=355698</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355698/355698-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355698</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>&#8220;9 Simple Solutions to Achieve Health Equity&#8221; Will Be Available as a FREE Download for Five Days on Amazon (ending 06/05/2026)</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355655</link>
     <pubDate>Wed, 3 Jun 2026 06:00:00 EDT</pubDate>
     <description><![CDATA[<p>  Best Seller Publishing  is pleased to announce a limited-time FREE eBook for  &#8220;9 Simple Solutions to Achieve Health Equity: A Guide for Healthcare Professionals and Patients&#8221;  by  Mauvareen Beverley, M.D., a nationally recognized expert in patient engagement and health equity. -   -  This timely and impactful book provides a clear, actionable roadmap for addressing disparities in healthcare and improving outcomes for underserved populations. -   -  With over two decades of experience advocating f...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355655">https://www.webwire.com/ViewPressRel.asp?aId=355655</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/40662/355655/355655-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355655</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355643</link>
     <pubDate>Tue, 2 Jun 2026 10:54:17 EDT</pubDate>
     <description><![CDATA[<p> The U.S. Food and Drug Administration (FDA) today issued  draft guidance  to help developers bring promising gene therapies to patients more efficiently by making greater use of existing scientific and regulatory knowledge. -   -  When finalized, the guidance will outline how sponsors can use publicly available information and established platform knowledge, including chemistry, manufacturing and controls (CMC) data, nonclinical study results and clinical information, to streamline regulatory...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355643">https://www.webwire.com/ViewPressRel.asp?aId=355643</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355643/355643-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355643</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Study Links Cannabis and Tobacco Co-Use to Lower Brain Performance in At-Risk Adolescents</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355642</link>
     <pubDate>Tue, 2 Jun 2026 10:50:35 EDT</pubDate>
     <description><![CDATA[<p> New research shows that among people at clinical high risk for psychosis, cannabis and tobacco co-use was associated with lower cognitive performance compared to healthy controls. The  novel study  appearing in   Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, published by Elsevier, fills a critical gap in research, providing clinicians and scientists with vital new insights into the risks associated with cannabis and tobacco co-use and the potential impact on vulnerable a...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355642">https://www.webwire.com/ViewPressRel.asp?aId=355642</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355642/355642-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355642</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>AMA statement on EO directing CDC to assess childhood vaccine schedule</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355567</link>
     <pubDate>Mon, 1 Jun 2026 12:15:33 EDT</pubDate>
     <description><![CDATA[<p>  Statement attributable to:  -   Bobby Mukkamala, MD  -  President, American Medical Association -   -  &#8220;There is no credible scientific evidence to support changing the current childhood vaccine schedule. That schedule is built on decades of rigorous research and real-world data, and it is designed to protect children in the U.S. when they are most vulnerable based on our nation&#39;s disease burden. -   -  &#8220;Altering it without clear, evidence-based justification risks continued confusion for parents and...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355567">https://www.webwire.com/ViewPressRel.asp?aId=355567</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355567/355567-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355567</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>WHO launches new guide to help scale psychological self-help</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355562</link>
     <pubDate>Mon, 1 Jun 2026 12:00:08 EDT</pubDate>
     <description><![CDATA[<p>   Psychological self-help interventions: delivering self-help for individuals, featuring Step-by-Step and Doing What Matters in Times of Stress   provides practical advice on planning, adapting and delivering self-help, with or without support from trained non-specialists. More than one billion people worldwide live with a mental health condition, yet many lack access to effective care. Psychological self-help interventions are one way to help close this gap, offering structured techniques...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355562">https://www.webwire.com/ViewPressRel.asp?aId=355562</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355562/355562-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355562</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>&#8220;I try to clean her wounds but my daughter screams in agony:&#8221; Dire conditions trap children in Gaza in an endless cycle of suffering</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355559</link>
     <pubDate>Mon, 1 Jun 2026 10:33:55 EDT</pubDate>
     <description><![CDATA[<p> &#8220;Failure to meet children&#39;s basic needs in Gaza is trapping them in an endless cycle of suffering.  -   -  &#8220;The experiences of the desperate parents I met this past week can illustrate this better than I could:  -   -  &#8220;Hind hasn&#39;t slept since her four-year-old daughter, Masa, was bitten by a rat during the night. -   -  &#8220;Like many families, they sheltered wherever they could &#8211; in their case, the second floor of a building block where sewage water leaks through the ceilings, and rodents crawl through...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355559">https://www.webwire.com/ViewPressRel.asp?aId=355559</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355559/355559-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355559</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Dr. Ashish Jha Headlines ConV2X Smart Technology Transformation Summit - NYC Oct 2026</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355445</link>
     <pubDate>Mon, 1 Jun 2026 08:00:00 EDT</pubDate>
     <description><![CDATA[<p> Partners in Digital Health today announced that Dr. Ashish Jha, one of the most influential voices in modern healthcare policy and public health leadership, will headline  ConV2X Smart Technology Transformation in Healthcare &amp; Life Sciences, taking place October 29&#8211;30, 2026, at the Historic GE Building:  ILR Conference Center in New York City. -   -  Dr. Jha serves as Senior Fellow at the Harvard Belfer Center and Co-Founder &amp; CEO of BioRadar. He previously served as White House COVID-19 Respo...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355445">https://www.webwire.com/ViewPressRel.asp?aId=355445</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/54628/355445/355445-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355445</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>CONV2X Decentralized Health &amp; Life Science Summit Releases FIRST SPEAKER COHORT</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355173</link>
     <pubDate>Mon, 1 Jun 2026 08:00:00 EDT</pubDate>
     <description><![CDATA[<p>Partners in Digital Health is proud to announce the first speaker cohort for ConV2X Decentralized Health &#8212; a landmark gathering of innovators, clinicians, technologists, and policy leaders reimagining the future of healthcare through decentralized infrastructure. -   -  This inaugural cohort represents some of the most consequential voices at the intersection of blockchain, AI, digital health, and regulatory science: -   -   Ajaz Hussain  &#8212; Former Deputy Director, Office of Pharmaceutical S</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355173">https://www.webwire.com/ViewPressRel.asp?aId=355173</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/54628/355173/355173-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355173</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Ennov Announces Strategic Growth Investment from Bregal Sagemount and Ardian</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355543</link>
     <pubDate>Mon, 1 Jun 2026 06:41:55 EDT</pubDate>
     <description><![CDATA[<p> Ennov (the &#8220;Company&#8221;), a global provider of end-to-end regulatory, quality, and clinical software solutions for life sciences and healthcare companies, announced a strategic growth investment led by Bregal Sagemount (&#8220;Sagemount&#8221;), a leading growth-focused private equity firm, with participation from Ardian, a global private investment firm. The investment will support the Company&#39;s continued expansion, with a focus on AI innovation, global go-to-market acceleration, and scaling its product...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355543">https://www.webwire.com/ViewPressRel.asp?aId=355543</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/7/355543/355543-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355543</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>&#8220;9 Simple Solutions to Achieve Health Equity&#8221; Will Be Available as a FREE Download for Five Days on Amazon (ending 06/05/2026)</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355522</link>
     <pubDate>Mon, 1 Jun 2026 06:00:00 EDT</pubDate>
     <description><![CDATA[<p>  Best Seller Publishing  is pleased to announce a limited-time FREE eBook for  &#8220;9 Simple Solutions to Achieve Health Equity: A Guide for Healthcare Professionals and Patients&#8221;  by  Mauvareen Beverley, M.D., a nationally recognized expert in patient engagement and health equity. -   -  This timely and impactful book provides a clear, actionable roadmap for addressing disparities in healthcare and improving outcomes for underserved populations. -   -  With over two decades of experience advocating f...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355522">https://www.webwire.com/ViewPressRel.asp?aId=355522</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/40662/355522/355522-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355522</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>New Memoir Chronicles a Soldier&#39;s Harrowing Survival and Journey Through the Veteran&#39;s Healthcare System</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355499</link>
     <pubDate>Fri, 29 May 2026 17:32:25 EDT</pubDate>
     <description><![CDATA[<p> In  &#8220;Lenin: A Soldier &#8211; A Story of Survival,&#8221;  Lenin Patino recounts the unimaginable: being shot point-blank in the head by a fellow soldier shortly after completing basic training. Left paralyzed and told he would not survive, Lenin defied every prediction. His memoir takes readers inside the hospital ward where he fought for his life, describing the friendships, tragedies, and struggles he witnessed among fellow patients. -   -   About the Book:  -  This is not just a survival story, it is a...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355499">https://www.webwire.com/ViewPressRel.asp?aId=355499</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/82679/355499/355499-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355499</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>&#8220;The Medical Deep&#8221; State by Curtis G. Graham MD - Amazon&#39;s Best-Selling Book Available for Free Download - Ending Soon (5/29/2026)</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355035</link>
     <pubDate>Fri, 29 May 2026 06:00:00 EDT</pubDate>
     <description><![CDATA[<p> Best Seller Publishing is proud to announce the release of  &#8220;The Medical Deep State: The Hidden System of Power That is Hijacking Medicine and How Physicians Can Reclaim Control of Their Career and Calling&#8221;  by physician, strategist, and healthcare advocate  Curtis G. Graham MD  &#8212; available for free download on Amazon for  one more day  &#8212;now through May 29, 2026. -   -  Across America, physicians are leaving medicine in record numbers. Burnout is skyrocketing, independent practices are collaps...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355035">https://www.webwire.com/ViewPressRel.asp?aId=355035</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/40662/355035/355035-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355035</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>1 in 3 Women Don&#39;t Know Menopause and Bone Loss Are Connected, New Osteoboost Data Reveals</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355386</link>
     <pubDate>Thu, 28 May 2026 12:00:00 EDT</pubDate>
     <description><![CDATA[<p> Osteoboost Health, the developer of the first and only FDA-cleared prescription medical device for low bone density, today released its inaugural  State of Bones Report, designed to shine a light on the perspectives and experiences of women and their bone health as they enter the perimenopause-menopause transition and beyond. -   -  The report is based on an independent surv</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355386">https://www.webwire.com/ViewPressRel.asp?aId=355386</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/42381/355386/355386-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355386</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Disney and Philips Bring Beloved Storytelling and Innovative Technology to Support Kids Undergoing MRI Exams</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355439</link>
     <pubDate>Thu, 28 May 2026 11:43:22 EDT</pubDate>
     <description><![CDATA[<p> The Walt Disney Company and Philips today announced that beloved Disney animated characters and stories are being incorporated directly into Philips Ambient Experience for MRI at medical facilities in  87 countries worldwide. For many children, this type of immersive environment can help shift attention away from the clinical setting, creating a more comforting and engaging experience during scans and helping more children complete their exams successfully. -   -  &#8220;At Disney, we believe storie...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355439">https://www.webwire.com/ViewPressRel.asp?aId=355439</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355439/355439-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355439</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Scars of Life: Study Shows Impact of Atopic Dermatitis on Educational and Career Choices</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355435</link>
     <pubDate>Thu, 28 May 2026 11:32:40 EDT</pubDate>
     <description><![CDATA[<p> Atopic dermatitis (AD), the most common form of eczema, impacts patients&#39; life trajectories beyond the physical scars. A  novel study  shows that adults with AD, particularly those with childhood onset, report significantly greater limitations in their educational and professional choices, with up to 38% of childhood-onset patients reporting career restrictions and more than 36% reporting constrained study choices, compared to individuals whose disease began in adulthood. The findings of t...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355435">https://www.webwire.com/ViewPressRel.asp?aId=355435</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355435/355435-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355435</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>MindMaze Therapeutics Chooses Connect Labs by Wexford at Charlotte&#39;s The Pearl Innovation District for U.S. Headquarters to Advance Neurological Care</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355378</link>
     <pubDate>Thu, 28 May 2026 09:00:00 EDT</pubDate>
     <description><![CDATA[<p>  MindMaze Therapeutics, a pioneer in precision neurotherapeutics, has announced a U.S headquarters at  The Pearl, Charlotte&#39;s Innovation District, a partnership between  Atrium Health  and  Wexford Science &amp; Technology, LLC. MindMaze has built a patient experience lab within  Connect Labs by Wexford, a flexible, scale-in-place lab and innovation infrastructure that facilitates frictionless entry into the Charlotte innovation ecosystem. The neurotherapy company joins world-class companies a...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355378">https://www.webwire.com/ViewPressRel.asp?aId=355378</a></p>]]></description>
     <guid isPermaLink="false">WebWireID355378</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Former Neurosurgeon Breaks His Silence on the Hidden Forces Reshaping Modern Medicine</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355353</link>
     <pubDate>Wed, 27 May 2026 12:34:53 EDT</pubDate>
     <description><![CDATA[<p> What happens when a doctor who dedicated his life to healing realizes the system no longer allows him to truly care for his patients? -   -  In  &#8220;Preparing to Tack: When Physicians Change Careers,&#8221;  Dr. Jack Kushner delivers a powerful and unflinching account of a lifetime in medicine, and the difficult decision to walk away from it. Inspired as a child by a defining encounter with life and death, Kushner entered medicine believing in the sacred bond between physician and patient. -   -  For decad...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355353">https://www.webwire.com/ViewPressRel.asp?aId=355353</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/82679/355353/355353-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355353</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>&#8220;The Medical Deep State&#8221; by Curtis G. Graham MD - Amazon&#39;s Best-Selling Book Available for Free Download - Ending Soon (5/29/2026)</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355034</link>
     <pubDate>Wed, 27 May 2026 06:00:00 EDT</pubDate>
     <description><![CDATA[<p> Best Seller Publishing is proud to announce the release of  &#8220;The Medical Deep State: The Hidden System of Power That is Hijacking Medicine and How Physicians Can Reclaim Control of Their Career and Calling&#8221;  by physician, strategist, and healthcare advocate  Curtis G. Graham MD  &#8212; available for free download on Amazon for  two more days  &#8212;now through May 29, 2026. -   -  Across America, physicians are leaving medicine in record numbers. Burnout is skyrocketing, independent practices are collap...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355034">https://www.webwire.com/ViewPressRel.asp?aId=355034</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/40662/355034/355034-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355034</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Weekly progress on share repurchase program to cover share plans and reduce capital</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355276</link>
     <pubDate>Tue, 26 May 2026 10:19:51 EDT</pubDate>
     <description><![CDATA[<p> dsm-firmenich, innovators in nutrition, health, and beauty, announced on February 9, 2026 its intention to repurchase ordinary shares with an aggregate market value of &#8364;500 million and reduce its issued capital. On March 12, 2026, the company commenced repurchasing ordinary shares for a total amount of &#8364;540 million, of which &#8364;40 million to cover commitments under the Group&#39;s share-based compensation plans and &#8364;500 million to reduce its issued capital. -   -  In accordance with regulations, dsm...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355276">https://www.webwire.com/ViewPressRel.asp?aId=355276</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355276/355276-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355276</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Angola, Burundi, Ethiopia and Zambia among countries benefiting from &#8364;10 million in EIB Global support for primary healthcare</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355275</link>
     <pubDate>Tue, 26 May 2026 10:09:36 EDT</pubDate>
     <description><![CDATA[<p> -    -  &#8226;  EIB Global provides &#8364;10 million to support the provision of technical assistance, catalysing potential investments into bankable projects in Sub-Saharan countries  -  &#8226;  The support is delivered through the Health Impact Investment Platform (HIIP), an initiative of EIB Global, Islamic Development Bank and World Health Organisation.  -    -   -   EIB Global, the European Investment Bank&#39;s development arm, has committed &#8364;10 million for a technical assistance programme aimed at supporting sub-...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355275">https://www.webwire.com/ViewPressRel.asp?aId=355275</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355275/355275-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355275</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Wiley Bolsters Research Integrity Efforts with Imagetwin&#39;s Enhanced Image Screening</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355273</link>
     <pubDate>Tue, 26 May 2026 10:00:47 EDT</pubDate>
     <description><![CDATA[<p> Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation and learning, today announced that it has integrated  Imagetwin&#39;s  leading AI-powered image integrity software into Research Exchange, its award-winning research publishing platform. The integration adds sophisticated AI-powered image detection to the 25+ research integrity checks already embedded in Research Exchange, enabling editors and integrity...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355273">https://www.webwire.com/ViewPressRel.asp?aId=355273</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355273/355273-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355273</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Why Doctors Are Burning Out? - &#8220;The Medical Deep State&#8221; by Curtis G. Graham MD - Free on Amazon Until 5/29/2026</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355033</link>
     <pubDate>Mon, 25 May 2026 06:00:00 EDT</pubDate>
     <description><![CDATA[<p> Best Seller Publishing is proud to announce the release of  &#8220;The Medical Deep State: The Hidden System of Power That is Hijacking Medicine and How Physicians Can Reclaim Control of Their Career and Calling&#8221;  by physician, strategist, and healthcare advocate  Curtis G. Graham MD �&#8211; available for free download on Amazon for a limited time&#8211;now through May 29, 2026. -   -  Across America, physicians are leaving medicine in record numbers. Burnout is skyrocketing, independent practices are collapsi...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355033">https://www.webwire.com/ViewPressRel.asp?aId=355033</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/40662/355033/355033-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355033</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>EBOLA OUTBREAK: &#34;Unless a collective effort is made, this crisis is going to get worse&#34;</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355098</link>
     <pubDate>Fri, 22 May 2026 12:08:10 EDT</pubDate>
     <description><![CDATA[<p> Save the Children is rushing to contain an Ebola outbreak in the  Democratic Republic of Congo, where decimated healthcare systems are ill equipped to stop its spread. -   -  At least 500 suspected cases of Ebola, and 130 deaths, have been reported in the DRC since the new outbreak began in early May, according to the  World Health Organization. -   -  As Save the Children prepares to launch a large-scale response to support local health systems and help Ebola-impacted families and children, the h...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355098">https://www.webwire.com/ViewPressRel.asp?aId=355098</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355098/355098-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355098</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>AMA on Ways and Means unanimously endorsing budget neutrality reform</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355096</link>
     <pubDate>Fri, 22 May 2026 10:59:04 EDT</pubDate>
     <description><![CDATA[<p>  Statement attributable to:  -   Bobby Mukkamala, MD  -  President, American Medical Association  -   -  &#8220;Physicians are grateful that the House Ways and Means Committee took a major step in curing a flawed budget policy that results in physicians facing Medicare cuts every year. Without reform, the Medicare Physician Fee Schedule produces a year-end budget mashup that injects uncertainty in physician practices due to the requirement that the fee schedule remain budget neutral. These cuts threaten...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355096">https://www.webwire.com/ViewPressRel.asp?aId=355096</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355096/355096-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355096</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Baxfendy approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355026</link>
     <pubDate>Thu, 21 May 2026 12:11:34 EDT</pubDate>
     <description><![CDATA[<p> AstraZeneca&#39;s  Baxfendy  (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive medications, to lower blood pressure in adults who are not adequately controlled. -   -  There are 1.4 billion people worldwide living with hypertension.1  In the US, approximately 50% of patients living with hypertension who are already taking multiple antihypertensive medications still struggle...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355026">https://www.webwire.com/ViewPressRel.asp?aId=355026</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355026/355026-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355026</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>AMA statement on HHS removing vice chairs of USPSTF</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355020</link>
     <pubDate>Thu, 21 May 2026 11:52:08 EDT</pubDate>
     <description><![CDATA[<p>  Statement attributable to:  -   Bobby Mukkamala, MD  -  President, American Medical Association -   -  &#8220;The AMA is extremely concerned by today&#39;s HHS decision to remove the vice-chairs of the U.S. Preventive Services Task Force (USPSTF). The task force serves an essential, non-partisan role in making evidence-based recommendations on clinical preventive services and screenings that physicians rely on to prevent disease. -   -  &#8220;Today&#39;s changes were foreshadowed by the earlier dismantling of the Advis...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355020">https://www.webwire.com/ViewPressRel.asp?aId=355020</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355020/355020-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355020</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>WHO and Gilead Sciences renew partnership to accelerate visceral leishmaniasis elimination</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355018</link>
     <pubDate>Thu, 21 May 2026 11:44:45 EDT</pubDate>
     <description><![CDATA[<p> The World Health Organization (WHO) and Gilead Sciences have renewed their partnership through a new five-year agreement (2026&#8211;2030) to support the elimination of visceral leishmaniasis (VL), a life-threatening neglected tropical disease. -   -  Under the agreement, Gilead Sciences will donate 402 941 vials of AmBisome (liposomal amphotericin B for injection) to treat visceral leishmaniasis and its complications in countries most affected by the disease. Gilead Sciences started donating this m...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355018">https://www.webwire.com/ViewPressRel.asp?aId=355018</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355018/355018-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355018</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Novel Mouse Model Mirrors Human Pathology of Geleophysic Dysplasia, Facilitating Research</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355007</link>
     <pubDate>Thu, 21 May 2026 11:08:02 EDT</pubDate>
     <description><![CDATA[<p> Researchers have developed a novel mouse model that replicates severe geleophysic dysplasia, including short stature, heart valve alterations, and early lethality&#8212;characteristics of this rare disease. The findings from the  study  in   The American Journal of Pathology, published by Elsevier, provide a basis for the identification of molecular mechanisms underlying geleophysic dysplasia, which can then be targeted for therapeutic purposes. -   -  Geleophysic dysplasia is a debilitating diseas...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355007">https://www.webwire.com/ViewPressRel.asp?aId=355007</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355007/355007-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355007</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Our AI Wearables Are &#8220;Changing the Game&#8221; for Disabled People</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354983</link>
     <pubDate>Thu, 21 May 2026 05:57:37 EDT</pubDate>
     <description><![CDATA[<p>  Takeaways   -   -    -  &#8226; We&#39;re rolling out new features on our AI glasses designed to be more intuitive and hands-free &#8212; updates that make the technology more accessible to people across diverse communities, including those who are blind or low vision, or those with mobility disabilities. -   -   &#8226; Our Meta Wearables Device Access Toolkit provides resources for developers to build third-party apps for our AI glasses that help people with disabilities navigate daily life with greater independence. - ...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354983">https://www.webwire.com/ViewPressRel.asp?aId=354983</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/7/354983/354983-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354983</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>New MRC investment supports clinical research careers in the UK</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354929</link>
     <pubDate>Wed, 20 May 2026 09:43:47 EDT</pubDate>
     <description><![CDATA[<p> The investment will establish 10 Regional Accounts for Clinical Researchers (RACR), bringing together more than 50 research organisations and over 60 NHS organisations across England, Scotland, Wales and Northern Ireland. -   -  RACR is a pilot initiative supporting clinicians at critical stages in their research careers to stay involved in research alongside clinical practice. -   -  The initiative will strengthen the UK&#39;s clinical research workforce, which underpins innovation, improved care and...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354929">https://www.webwire.com/ViewPressRel.asp?aId=354929</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/7/354929/354929-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354929</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>&#8220;Brain Signatures Whisper Warnings:&#8221; Researchers Identify Age 9 as Critical Turning Point for Anxiety and Depression</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354895</link>
     <pubDate>Tue, 19 May 2026 12:22:32 EDT</pubDate>
     <description><![CDATA[<p> A  longitudinal study  tracking children over a period of seven years identified distinct brain-wave patterns emerging from age 9 can forecast a child&#39;s vulnerability to anxiety or depression by age 13. These predictive markers reveal divergent, hemisphere-specific neurodevelopmental trajectories. Anxiety is linked to activity on the right side of the brain, while depression is tied to the left. The findings from the novel study in   Biological Psychiatry, published by Elsevier, provide a...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354895">https://www.webwire.com/ViewPressRel.asp?aId=354895</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/354895/354895-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354895</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>UNICEF scaling up efforts to protect and support children and families following Ebola outbreaks in the Democratic Republic of the Congo and Uganda</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354890</link>
     <pubDate>Tue, 19 May 2026 12:05:35 EDT</pubDate>
     <description><![CDATA[<p> &#8220;UNICEF is deeply concerned by confirmed Ebola outbreaks in the Democratic Republic of the Congo (DRC) and Uganda, and the growing risk to children and vulnerable communities across the region &#8211; a situation the World Health Organization has now declared a Public Health Emergency of International Concern. -   -  &#8220;A total of 246 suspected cases have been reported so far, with 80 suspected deaths recorded in Ituri Province, eastern DRC, and Uganda has also reported two cases, with one death. The...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354890">https://www.webwire.com/ViewPressRel.asp?aId=354890</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/354890/354890-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354890</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Aon&#39;s New AI-Powered Health Network Analyzer Helps U.S. Employers Make Smarter Network Choices and Reduce Medical Spend</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=354883</link>
     <pubDate>Tue, 19 May 2026 11:41:04 EDT</pubDate>
     <description><![CDATA[<p>  Aon plc  (NYSE: AON), a leading global professional services firm, announced the launch of its Health Network Analyzer, a new AI-powered decision-support capability that enables U.S. employers to quantify the cost, quality and access of offerings across traditional and alternative health plan networks. -   -  As U.S. employer healthcare costs are  projected  to grow by 9.5 percent in 2026, benefits leaders are reprioritizing how they manage spend. According to Aon&#39;s 2026 Employer Benefits Sur...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=354883">https://www.webwire.com/ViewPressRel.asp?aId=354883</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/354883/354883-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID354883</guid>
     <dc:type>Article</dc:type>
  </item>

  </channel>
</rss>
